GlobeNewsWire
30 Jun 2026, 12:45 UTC · 20w ago
Vivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
Impact · against what's priced in
Vivos Therapeutics introduces a potential new revenue growth driver with positive clinical data for the Vida appliance in treating insomnia. While the 100% success rate is a strong signal, the small sample size (37 patients) and single-site nature of the study limit immediate scalability and introduce execution risk.
- VVOS+0.60
No priced-in read yet





